SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493152-21-018514
Filing Date
2021-08-04
Accepted
2021-08-04 09:43:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13ga.htm SC 13G/A 106688
  Complete submission text file 0001493152-21-018514.txt   108265
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Subject) CIK: 0001610820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: SC 13G/A | Act: 34 | File No.: 005-92289 | Film No.: 211142617
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 FIRST CANADIAN PLACE 39TH FLOOR TORONTO A6 M5X 1H3
Business Address 1 FIRST CANADIAN PLACE 39TH FLOOR TORONTO A6 M5X 1H3 5142437438
L5 Capital Inc. (Filed by) CIK: 0001869759 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A